71 IAC 8.5-1-5 Furosemide as a permitted foreign substance

Sec. 5. (a) Furosemide may be administered intravenously to a horse that is entered to compete in a race under the following conditions: (1) The horse's licensed trainer, or a licensed veterinarian, determines that it would be in the horse's best interests to race with furosemide. (2) Notice that a horse eligible to race on furosemide will race, with or without furosemide, shall be made at the time of entry to ensure public notification, including publication in the official racing program. (3) If a horse's licensed trainer, or a licensed veterinarian, determines that it is no longer in the horse's best interests to race with furosemide, the horse shall not be eligible to receive furosemide unless the licensed trainer, or a licensed veterinarian, later determines that it would be in the horse's best interests to resume furosemide treatments for racing, and the licensed trainer or licensed veterinarian complies with the requirements of this section. (4) Furosemide shall only be administered on association grounds. (5) Upon the request of the commission or its designee, the veterinarian administering furosemide shall surrender the syringe used to administer such medication, which may then be submitted for testing. (6) A horse eligible to receive furosemide must be treated at least four (4) hours, and not more than four (4) hours and twenty-five (25) minutes, prior to the scheduled post time of its race. (7) Furosemide shall be administered by a veterinarian licensed by the commission at an intravenous dose level not to exceed five hundred (500) milligrams and not less than one hundred fifty (150) milligrams. Administration of furosemide shall take place in the test barn or a specific location otherwise designated by the commission. An association employee shall be present and observe the drawing of furosemide into a syringe. The administering veterinarian shall provide a factory sealed bottle of furosemide from which the draws shall be made. The association shall establish track rules for furosemide administrations that are consistent with these regulations. (8) The test level of furosemide under this rule shall not be in excess of one hundred (100) nanograms per milliliter of serum or plasma and shall not be below a urine specific gravity of one and ten one-thousandths (1.010). If an insufficient volume of urine is obtained, a positive test shall be based upon quantitative testing performed on blood serum or plasma only. Split sample testing shall be quantitative and be performed on blood serum or plasma only. (b) It shall constitute a violation of these rules if notice is made pursuant to this section that a horse will race with furosemide, and a post-race sample of urine, serum, or plasma obtained from that horse does not contain furosemide at a level detectable by the official commission laboratory.